title: Metabolic and drug distribution studies do not support direct inhibitory effects of metformin on intestinal glucose absorption.
abstract: In an attempt to clarify the question of an involvement of the inhibition of intestinal glucose absorption in the mechanism of action of Metformin, we used several experimental approaches: 1 glucose/lactate measurement in rat portal blood in vivo and 2 in the venous effluent of an isolated perfused rat intestinal segment; 3 metabolism of freshly isolated enterocytes in vitro and tissue distribution of 3H-labeled Metformin was investigated both in vivo and in vitro. Metformin applied intraluminally had no significant effect on portal glycaemia after a glucose load, but lactate increased, whereas in vivo only a high Metformin dosage reduced portal glucose appearance significantly. Although high Metformin concentrations were found in gut biopsies, precise histological analysis in the isolated intestine revealed that it was absent from enterocytes; however the drug accumulated in villous lacteals. Intrarterially applied Metformin decreased glucose absorption in the isolated perfused ileo-jejunal segment. These data suggested that vascular Metformin boosted intestinal anaerobic glucose metabolism. Biochemical measurements performed on freshly isolated enterocytes showed that even high Metformin levels did not interfere with cell respiration or with Na+/K+ ATPase activity. Thus, our data agree with other recent reports, suggesting that even at nontherapeutic concentrations Metformin has no relevant inhibitory effect on intestinal glucose absorption. The data are discussed in the frame of previous divergent observations. The results suggest however that Metformin of vascular origin stimulates glucose consumption by the intestine, which then increases lactate output from the gut.
authors.affiliation: INSERM U45, Hôpital E. Herriot, Lyon.
authors.forename: J C
authors.initials: JC
authors.lastname: Cuber
authors.forename: A
authors.initials: A
authors.lastname: Bosshard
authors.forename: H
authors.initials: H
authors.lastname: Vidal
authors.forename: F
authors.initials: F
authors.lastname: Vega
authors.forename: N
authors.initials: N
authors.lastname: Wiernsperger
authors.forename: J R
authors.initials: JR
authors.lastname: Rapin
mesh_terms: D000818:Animals; D005947:Glucose / Q000378:metabolism*; D066298:In Vitro Techniques; D007408:Intestinal Absorption / Q000187:drug effects*; D007422:Intestines / Q000166:cytology / Q000187:drug effects; D008297:Male; D008687:Metformin / Q000493:pharmacokinetics / Q000494:pharmacology*; D010477:Perfusion; D051381:Rats; D017208:Rats, Wistar; D014018:Tissue Distribution / Q000502:physiology
chemical_list: D008687:Metformin; D005947:Glucose